Embla Medical hf (OTCPK:OSSFF)
$ 5.1 0 (0%) Market Cap: 2.11 Bil Enterprise Value: 2.57 Bil PE Ratio: 31.48 PB Ratio: 2.87 GF Score: 79/100

Q1 2023 Ossur hf Earnings Call Transcript

Apr 25, 2023 / 07:00AM GMT
Release Date Price: $4.8
Operator

Good day, and thank you for standing by. Welcome to the Ossur Q1 2023 Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Sveinn Solvason, President and CEO. Please go ahead.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you all to the Ossur investor conference call, where we will cover the results for the first quarter. My name is Sveinn Solvason, and I'm the President and CEO. And with me here today is Arna Sveinsdottir, our CFO. We will begin by going through some of the highlights here in quarter 1 and ending with our guidance for 2023. A question-and-answer session will then follow.

If you go to the next slide, please. We want to -- yes, [want to go through] some of the main topics. This is the first quarter where we are reporting according to our new sales segmentation, which includes 3 business segments: Prosthetics,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot